Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mirza Suljagic"'
Autor:
Esma Bilajac, Lejla Mahmutović, Una Glamočlija, Amar Osmanović, Altijana Hromić-Jahjefendić, Murtaza M. Tambuwala, Mirza Suljagić
Publikováno v:
Metabolites, Vol 13, Iss 1, p 58 (2022)
Chronic myeloid leukemia (CML) is a myeloproliferative haematological malignancy characterized by constitutive activation of BCR-ABL1 tyrosine kinase in the majority of patients. BCR-ABL1 expression activates signaling pathways involved in cell proli
Externí odkaz:
https://doaj.org/article/e759d15870f54a63884596b104ed4850
Autor:
Una Glamoclija, Lejla Mahmutovic, Esma Bilajac, Violeta Soljic, Katarina Vukojevic, Mirza Suljagic
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Chemotherapy resistance is one of the major challenges in cancer treatment, including leukemia. A massive array of research is evaluating combinations of drugs directed against different intracellular signaling molecules to overcome cancer resistance
Externí odkaz:
https://doaj.org/article/e4620f43516a4b5bb51f86a13a6db159
Autor:
Jasminka, Prguda-Mujic, Karin, Milde-Langosch, Volkmar, Mueller, Mirza, Suljagic, Jozo, Coric, Daria, Ler
Publikováno v:
Annals of clinical and laboratory science. 48(2)
Metastasis-Associated in Colon Cancer-1(MACC1) was first identified as a transcriptional activator of the HGF/MET pathway. Deregulation of HGF/MET signaling is reported as a prognostic marker for tumorigenesis, early stage invasion, and metastasis wh
Publikováno v:
Karamehmedović, M, Sehic, K, Dammann, B, Suljagić, M & Karamehmedović, E 2019, ' Autoencoder-aided measurement of concentration from a single line of speckle ', Optics Express, vol. 27, no. 20, pp. 29098-29123 . https://doi.org/10.1364/OE.27.029098
We demonstrate that a single 6mm line sample of simulated near-field speckleintensity suffices for accurate estimation of the concentration of dielectric micro-particles over a range from 104 to 6 · 106 particles per ml. For this estimation, we anal
Autor:
Mirza Suljagic, Luca Laurenti, Dimitar G. Efremov, Michela Tarnani, Sami N. Malek, Muhammad Mansoor Alam
Publikováno v:
Leukemia. 24(12)
The PI3K/Akt pathway is activated in response to various microenvironmental stimuli that regulate the survival and proliferation of chronic lymphocytic leukemia (CLL) B-cells, including triggering of the B-cell receptor (BCR). Although this pathway i
Autor:
Mirza Suljagic, Dimitar G. Efremov, Pablo G. Longo, Emerald Perlas, Giuseppe Leone, Luca Laurenti, Sara Bennardo
Publikováno v:
Blood. 116(23)
Inhibition of antigen-dependent B-cell receptor (BCR) signaling is considered a promising therapeutic approach in chronic lymphocytic leukemia (CLL), but experimental in vivo evidence to support this view is still lacking. We have now investigated wh
Autor:
Dimitar G. Efremov, Julia Eckl-Dorna, Daniel Bilbao, Stephen H. Clarke, Hongsheng Wang, Stefano Iacovelli, Richard J. Cornall, Mirza Suljagic, Stefania Gobessi, Carlo M. Croce, Sara Bennardo
Publikováno v:
Blood. 120:181-181
Abstract 181 Studies conducted over the past decade have revealed a strong association between the mutational status of the immunoglobulin heavy-chain variable region (IGHV) genes and clinical course in patients with chronic lymphocytic leukemia (CLL
Publikováno v:
Blood. 114:887-887
Abstract 887 CLL B-cells depend on various signals from the microenvironment for survival and proliferation. Among these, antigenic stimuli that are propagated through the B-cell receptor (BCR) are considered particularly important for the developmen
Autor:
Luca Laurenti, Mirza Suljagic, Dimitar G. Efremov, Pablo G. Longo, Sami N. Malek, Muhammad Mansoor Alam
Publikováno v:
Blood. 112:2080-2080
The PI3K/AKT pathway plays a central role in regulating cellular growth and survival. This pathway is activated by signals derived from various receptors and is tightly regulated through the action of several phosphatases, including SHIP and PTEN, wh
Autor:
Mirza Suljagic, Richard J. Cornall, Stefania Gobessi, Verena Niederberger, Luca Laurenti, Julia Eckl-Dorna, Francesco Bertoni, Giulia Bolasco, Andrea Rinaldi, Stephen H. Clarke, Daniel Bilbao, Hassan Jumaa, Marcus Duehren-von Minden, Stefano Iacovelli, Eva Hug, Simona Sica, Dimitar G. Efremov, Sara Bennardo, Hongsheng Wang, Francesco Autore, Carlo M. Croce
Publikováno v:
Europe PubMed Central
Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy characterized by a highly variable course and outcome. The disease is believed to be driven by B-cell receptor (BCR) signals generated by external antigens and/or cell-autonomous BCR in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9113f9240aaac24da2286bc98f787bce
http://europepmc.org/abstract/med/25564405
http://europepmc.org/abstract/med/25564405